Resection of the Primary Tumor Followed by Peptide Receptor Radionuclide Therapy as Upfront Strategy for the Treatment of G1-G2 Pancreatic Neuroendocrine Tumors with Unresectable Liver Metastases.
about
Surgical resection of primary tumor improves survival of pancreatic neuroendocrine tumor with liver metastases.Role of palliative resection of the primary pancreatic neuroendocrine tumor in patients with unresectable metastatic liver disease: a systematic review and meta-analysis.Successful neoadjuvant peptide receptor radionuclide therapy for an inoperable pancreatic neuroendocrine tumour.
P2860
Resection of the Primary Tumor Followed by Peptide Receptor Radionuclide Therapy as Upfront Strategy for the Treatment of G1-G2 Pancreatic Neuroendocrine Tumors with Unresectable Liver Metastases.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Resection of the Primary Tumor ...... Unresectable Liver Metastases.
@en
type
label
Resection of the Primary Tumor ...... Unresectable Liver Metastases.
@en
prefLabel
Resection of the Primary Tumor ...... Unresectable Liver Metastases.
@en
P2093
P2860
P50
P1476
Resection of the Primary Tumor ...... Unresectable Liver Metastases
@en
P2093
Chiara Grana
Claudio Zardini
Davide Radice
Emilio Bertani
Francesca Spada
Lisa Bodei
Massimo Falconi
P2860
P2888
P304
P356
10.1245/S10434-016-5550-3
P433
P577
2016-09-09T00:00:00Z
P6179
1003752023